Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.

Corticosteroid-binding globulin (CBG), a negative acute phase protein produced primarily in the liver, is responsible for the transport of glucocorticoids (GCs). It also modulates the bioavailability of GCs, as only free or unbound steroids are biologically active. Fluctuations in CBG levels therefo...

Full description

Bibliographic Details
Main Authors: Nicolette Verhoog, Fatima Allie-Reid, Wim Vanden Berghe, Carine Smith, Guy Haegeman, Janet Hapgood, Ann Louw
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4205011?pdf=render
_version_ 1817990151981236224
author Nicolette Verhoog
Fatima Allie-Reid
Wim Vanden Berghe
Carine Smith
Guy Haegeman
Janet Hapgood
Ann Louw
author_facet Nicolette Verhoog
Fatima Allie-Reid
Wim Vanden Berghe
Carine Smith
Guy Haegeman
Janet Hapgood
Ann Louw
author_sort Nicolette Verhoog
collection DOAJ
description Corticosteroid-binding globulin (CBG), a negative acute phase protein produced primarily in the liver, is responsible for the transport of glucocorticoids (GCs). It also modulates the bioavailability of GCs, as only free or unbound steroids are biologically active. Fluctuations in CBG levels therefore can directly affect GC bioavailability. This study investigates the molecular mechanism whereby GCs inhibit the expression of CBG. GCs regulate gene expression via the glucocorticoid receptor (GR), which either directly binds to DNA or acts indirectly via tethering to other DNA-bound transcription factors. Although no GC-response elements (GRE) are present in the Cbg promoter, putative binding sites for C/EBPβ, able to tether to the GR, as well as HNF3α involved in GR signaling, are present. C/EBPβ, but not HNF3α, was identified as an important mediator of DEX-mediated inhibition of Cbg promoter activity by using specific deletion and mutant promoter reporter constructs of Cbg. Furthermore, knockdown of C/EBPβ protein expression reduced DEX-induced repression of CBG mRNA, confirming C/EBPβ's involvement in GC-mediated CBG repression. Chromatin immunoprecipitation (ChIP) after DEX treatment indicated increased co-recruitment of C/EBPβ and GR to the Cbg promoter, while C/EBPβ knockdown prevented GR recruitment. Together, the results suggest that DEX repression of CBG involves tethering of the GR to C/EBPβ.
first_indexed 2024-04-14T00:55:06Z
format Article
id doaj.art-0ae8bc14c40840db8f921502d402b6c9
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-14T00:55:06Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-0ae8bc14c40840db8f921502d402b6c92022-12-22T02:21:37ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01910e11070210.1371/journal.pone.0110702Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.Nicolette VerhoogFatima Allie-ReidWim Vanden BergheCarine SmithGuy HaegemanJanet HapgoodAnn LouwCorticosteroid-binding globulin (CBG), a negative acute phase protein produced primarily in the liver, is responsible for the transport of glucocorticoids (GCs). It also modulates the bioavailability of GCs, as only free or unbound steroids are biologically active. Fluctuations in CBG levels therefore can directly affect GC bioavailability. This study investigates the molecular mechanism whereby GCs inhibit the expression of CBG. GCs regulate gene expression via the glucocorticoid receptor (GR), which either directly binds to DNA or acts indirectly via tethering to other DNA-bound transcription factors. Although no GC-response elements (GRE) are present in the Cbg promoter, putative binding sites for C/EBPβ, able to tether to the GR, as well as HNF3α involved in GR signaling, are present. C/EBPβ, but not HNF3α, was identified as an important mediator of DEX-mediated inhibition of Cbg promoter activity by using specific deletion and mutant promoter reporter constructs of Cbg. Furthermore, knockdown of C/EBPβ protein expression reduced DEX-induced repression of CBG mRNA, confirming C/EBPβ's involvement in GC-mediated CBG repression. Chromatin immunoprecipitation (ChIP) after DEX treatment indicated increased co-recruitment of C/EBPβ and GR to the Cbg promoter, while C/EBPβ knockdown prevented GR recruitment. Together, the results suggest that DEX repression of CBG involves tethering of the GR to C/EBPβ.http://europepmc.org/articles/PMC4205011?pdf=render
spellingShingle Nicolette Verhoog
Fatima Allie-Reid
Wim Vanden Berghe
Carine Smith
Guy Haegeman
Janet Hapgood
Ann Louw
Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
PLoS ONE
title Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
title_full Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
title_fullStr Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
title_full_unstemmed Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
title_short Inhibition of corticosteroid-binding globulin gene expression by glucocorticoids involves C/EBPβ.
title_sort inhibition of corticosteroid binding globulin gene expression by glucocorticoids involves c ebpβ
url http://europepmc.org/articles/PMC4205011?pdf=render
work_keys_str_mv AT nicoletteverhoog inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT fatimaalliereid inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT wimvandenberghe inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT carinesmith inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT guyhaegeman inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT janethapgood inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb
AT annlouw inhibitionofcorticosteroidbindingglobulingeneexpressionbyglucocorticoidsinvolvescebpb